Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced the establishment of LataMed AI VE, C.A., a new Venezuelan operating subsidiary intended to support the Company’s telehealth regulatory, commercialization, and healthcare deployment initiatives within Venezuela. The subsidiary is expected to serve as a principal localized operating entity for the phased deployment of the Company’s telehealth platform, broader healthcare delivery infrastructure, and regulatory progression efforts.
Management anticipates that operational activities through LataMed AI VE, C.A. may commence in the coming weeks, subject to continued regulatory progression, operational readiness, and broader commercialization planning. The subsidiary is expected to work alongside the Company’s existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy designed to strengthen local regulatory flexibility, healthcare service operations, permit management, and long-term commercialization scalability.
The establishment of LataMed AI VE, C.A. is seen as a significant step to enhance the Company’s ability to efficiently manage localized healthcare operations, support phased commercialization initiatives, improve operational deployment readiness, and facilitate broader telehealth platform expansion across Venezuela and other targeted Latin American markets. The subsidiary is expected to support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management.
Catalyst Crew continues to advance telehealth platform development, pilot deployment readiness, regulatory progression, healthcare analytics integration, and broader commercialization initiatives through its digital healthcare ecosystem, including active platform development and testing through its telehealth interface at https://latamedai.org.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.”
The Company continues to coordinate regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives. For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
The implications of this announcement are significant for the telehealth industry and emerging markets. By establishing a localized subsidiary, Catalyst Crew aims to navigate regulatory complexities more effectively, potentially accelerating the deployment of telehealth services in Venezuela. This move could improve healthcare access in underserved regions, demonstrating a scalable model for other Latin American markets. For investors, this signals progress in the Company’s strategic transition into AI-enabled healthcare, though risks remain as the Company is a development-stage enterprise with no revenues from its current direction.
